Kadir Uludag | Educational Psychology | Educational Psychology Impact

Dr. Kadir Uludag | Educational Psychology | Educational Psychology Impact

Dr. Kadir Uludag is a postdoctoral researcher in psychology with a Ph.D. in Applied Psychology from the University of Chinese Academy of Sciences. His research bridges schizophrenia, brain imaging, and educational psychology. Dr. Uludag is passionate about disseminating scientific knowledge through his personal website (ifx0.com/psychology), YouTube channel (youtube.com/boooringlearning), and as the founder of the open-access journal Novelty in Psychology. He has published extensively, including 12 Web of Science (Q1) and 21 Scopus-indexed works, and serves on the editorial boards of 24 international journals. With over 670 manuscript reviews listed on ORCID, he has received multiple awards recognizing his scientific contributions. Dr. Uludag also manages four ongoing book projects. Skilled in Python-based machine learning and data analysis tools, he is eager to collaborate on innovative research that contributes meaningfully to psychology and society.

Profile

Education šŸŽ“

Dr. Uludag earned his Ph.D. in Applied Psychology from the University of Chinese Academy of Sciences (2019–2023, GPA 3.93), focusing on brain imaging and mental health. He completed an M.A. in Forensic Sciences (Social Sciences) from Istanbul University (2016–2018, GPA 3.61), where he developed a strong foundation in psychological evaluation in legal settings. His undergraduate degree in Psychological Counseling and Guidance was obtained from Ƈanakkale Onsekiz Mart University (2012–2016, GPA 3.30), complemented by an associate degree in Laboratory Assistant and Veterinary Sciences from Eskisehir Anatolian University (2013–2015, GPA 3.79). He has also pursued training in TESOL, SPSS, machine learning (random forest, SVM, logistic regression, neural networks), Python programming, web development, and data visualization. His education has been guided by distinguished scholars including Prof. Xiang Yang Zhang, Prof. Erdinc Ozturk, and Prof. Neylan Ziyal. These experiences shaped his multidisciplinary approach to psychological research.

Experience šŸ‘Øā€šŸ«

Dr. Kadir Uludag is currently a postdoctoral researcher at Shanghai Jiao Tong University (2023–Present) and has been appointed for a future role at Capital Medical University, Beijing (2025–). His expertise spans schizophrenia, neuroimaging, and educational psychology. Previously, he served as a special education teacher for autistic children at Karabük Municipality Autistic Children Education Center (2017), applying cognitive-behavioral and humanistic therapeutic approaches. He also completed internships as a psychological counselor at Toki Anadolu Lisesi (2016) and a veterinary technician at Safranbolu Veterinary Clinic (2015). He brings in-depth knowledge of psychological development and intervention techniques across diverse settings. In academia, Dr. Uludag serves on the editorial boards of 24 journals and has edited four book projects. His dynamic involvement in teaching, research, editing, and mentoring reflects a holistic commitment to the field of psychology and science communication.

Awards & Recognitions šŸ…

Dr. Uludag has received numerous accolades, including the ā€œHighest Number of Viewsā€ award (2023–2024) from the Journal of Clinical and Basic Psychosomatics for his narrative review on smoking and schizophrenia. He earned reviewer awards from Imeta Journal and Imetaomics for reviewing more than five papers each. Additionally, he holds a Certificate of Excellence from the Shanghai Table Tennis Museum and the American Chemical Society Reviewer Lab Certificate. His extensive peer-review contributions (over 670 reviews) are recognized by ORCID and editorial teams worldwide. His editorial involvement includes serving on boards of journals like Health Policy and Technology, Plos One, and Asean Journal of Psychiatry, among others. He has received invitations for guest editorships and honorary memberships in various scholarly outlets. These honors reflect his impactful presence in academia and his dedication to advancing global psychological research.

Research Interests šŸ”¬

Dr. Kadir Uludag’s primary research interests include schizophrenia, neuroimaging (fMRI and EEG), and educational psychology. His doctoral work applied Python-based machine learning (random forest, SVM, logistic regression) to brain imaging data, emphasizing computational psychiatry and precision diagnostics. He has published in Q1 journals such as Asian Journal of Psychiatry, American Chemical Neuroscience, Psychology Research and Behavior Management, General Psychiatry, and Antioxidants. His Scopus-indexed contributions span educational psychology, forensic science, and neuroscience. His research applies interdisciplinary tools—Python, Psychopy, SPSS, R, NLP, and image processing libraries—to explore psychiatric conditions. He integrates theory and practice through data visualization, cognitive-behavioral therapy models, and open-science advocacy. Dr. Uludag actively shares findings via his YouTube channel and academic website, fostering transparency and education. His work aims to bridge gaps between neuroscience, education, and technology to improve mental health outcomes and knowledge dissemination.

Publications

Gerd Fabian Volk | Cognitive Rehabilitation | Outstanding Scientist Award

Dr. Gerd Fabian Volk | Cognitive Rehabilitation | Outstanding Scientist Award

apl. Prof. Dr. med. habil. Gerd Fabian Volk (šŸ‘¶1978, Wertheim am Main) is a leading German otolaryngologist šŸ‘Øā€āš•ļø, currently serving as Senior Physician and Head of the Facial Nerve Center in Jena šŸ„. With a deep commitment to clinical excellence, academic teaching šŸ“š, and innovative research 🧪, he has significantly contributed to the fields of neurolaryngology, facial nerve disorders, and ultrasound diagnostics šŸ§ šŸ—£ļø. His work bridges cutting-edge imaging šŸ–¼ļø and functional diagnostics for head-neck disorders. Living in Jena with his family šŸ‘Øā€šŸ‘©ā€šŸ‘§ā€šŸ‘§, he actively supports patient education through YouTube šŸ“¹, coordinates national workshops, and advocates for interdisciplinary collaboration šŸ¤. Volk is a respected speaker šŸŽ¤, faculty member at international dissection courses āœ‚ļøšŸ§ , and an initiator of hybrid symposia. He balances leadership with education, translating research into real-world clinical impact šŸŒšŸ’”.

Profile

Education šŸŽ“

Studied human medicine at WestfƤlische Wilhelms UniversitƤt Münster (1999–2006) šŸŽ“šŸ©ŗ, earning his state exam. In 2007, he completed his doctorate (Dr. med.) with a thesis on axonal regeneration in retinal ganglion cells in primates and rats šŸ§¬šŸ’šŸ€. He achieved board certification in ENT (2012) šŸ‘‚šŸ‘ƒšŸ§  and earned his postdoctoral qualification (habilitation) in 2017 with pioneering research on quantitative imaging of facial muscles šŸ–¼ļøšŸ’Ŗ. His venia legendi was granted by Friedrich Schiller University Jena in otorhinolaryngology šŸ“œšŸ‘Øā€šŸ«. Further qualifications include DEGUM Level II (2018) for ultrasound, clinical trial leadership certification (2009), animal research leadership certification (2002), and interdisciplinary leadership training at UKJ šŸ…šŸ“Š. His broad educational background underpins his medical, scientific, and didactic work, combining clinical care, diagnostics, and teaching for the next generation of ENT specialists šŸ‘Øā€āš•ļøšŸ‘©ā€āš•ļøšŸ‘Øā€šŸ«.

Experience šŸ‘Øā€šŸ«

Since 2013, Dr. Volk leads the Facial Nerve Center in Jena and co-founded the Tinnitus Center šŸ‘Øā€āš•ļøšŸ”Š. He is currently Senior Physician at the ENT Department, University Hospital Jena and member of the steering committee for the Center for Rare Diseases Jena (since 2024) 🧩🧬. He previously held rotational research fellowships in radiology and neurology (2008–2013) and has organized national ENT courses since 2009 šŸ§ šŸŽ“. With consistent academic teaching since 2012, he has led cadaver dissection courses, neurolaryngology workshops, and ultrasound diagnostics trainings šŸ§‘ā€šŸ«šŸ’». He is an active contributor to ethics commissions and rare disease networks šŸ‘„āš–ļø. His work merges clinical ENT practice, surgical skill, and educational outreach through digital platforms (e.g., YouTube, www.lemg.org) šŸŒšŸ“¹. A devoted mentor, he organizes monthly PhD symposia and integrates hybrid teaching formats, balancing high-level medical care with forward-thinking academic initiatives šŸ“ššŸ„šŸŽÆ.

Awards & Recognitions šŸ…

Recipient of multiple national prizes, including the 1st Poster Prize by the German Society for Ultrasound in Medicine (2019) šŸ„‡šŸ“Š for Parkinson-related facial muscle imaging, and the DEGUM Head-Neck Section Award for his habilitation research (2018) šŸ§ šŸ…. Awarded competitive IZKF research fellowships in neurology and radiology (2008–2013) šŸ§¬šŸ”¬. Recognized leader in rare disease diagnostics and member of Germany’s CRANIO-Net for rare craniofacial disorders (since 2022) šŸ§©šŸ‘¶. Since 2020, he contributes to the Ethics Commission of the University Hospital Jena āš–ļø. He is speaker for ENT indications in the Botulinumtoxin Working Group of the German Society of Neurology (since 2022) šŸ’‰šŸ§ . Nominated for professorial posts in Bielefeld, Halle, and CharitĆ© Berlin between 2019–2023 šŸ›ļøšŸ“š. Volk’s sustained excellence across clinical care, diagnostics, research, and education has earned him national recognition and leadership roles in academic ENT medicine šŸ§ šŸ„āœØ.

Research Interests šŸ”¬

Prof. Volk’s research centers on facial nerve diagnostics and therapy šŸ§ šŸ§‘ā€āš•ļø, neurolaryngology, and ultrasound imaging of head-neck structures šŸ–¼ļø. He specializes in quantitative imaging of facial muscles for conditions like facial paralysis and Parkinson’s disease šŸ¤–šŸ§ . His work combines clinical neurophysiology, MRI analysis, and laryngeal electromyography (LEMG) šŸ“ˆšŸ’¬. He also pioneers educational innovations in hybrid learning, simulation-based teaching, and cadaver dissection techniques for ENT and neurology professionals šŸ§‘ā€šŸ«šŸ§Ŗ. Through platforms like www.lemg.org and dedicated YouTube channels šŸ“¹, he disseminates knowledge on advanced diagnostics such as salivary duct endoscopy, voice disorders, and botulinum toxin use šŸ’‰. A strong advocate for interdisciplinary networks and rare disease research, he leads initiatives in patient-centered care, including organizing the ā€œFazialis-Nerv-Tagā€ and supporting patient education šŸ¤ā¤ļø. His translational research aims to enhance diagnostic precision and develop novel rehabilitation strategies for complex craniofacial disorders šŸ§¬šŸ”§.

PublicationsĀ 
  • Electromyography as an Objective Outcome Measure for the Therapeutic Effect of Biofeedback Training to Reduce Post-Paralytic Facial Synkinesis

    Healthcare
    2025-03-04 |Ā Journal article
    CONTRIBUTORS:Ā Isabell Hahnemann;Ā Julia Fron;Ā Jonas Ballmaier;Ā Orlando Guntinas-Lichius;Ā Gerd Fabian Volk
  • Evaluation of the Effects of an Electromyography-Based Bio-Feedback Training of Patients with Post-Paralytic Facial Synkinesis Using Electromyography Amplitudes as Objective Outcome Measure

    2024-12-16 |Ā Preprint
    CONTRIBUTORS:Ā Isabell Hahnemann;Ā Julia Fron;Ā Jonas Ballmaier;Ā Orlando Guntinas-Lichius;Ā Gerd Fabian Volk
  • Deceleration of denervated facial muscle atrophy through functional electrical stimulation: a sonographic quantification in patients with facial nerve paralysis

    European Journal of Translational Myology
    2024-11-13 |Ā Journal article
    CONTRIBUTORS: Gabriel Meincke; Johannes Krauß; Maren Geitner; Anna-Maria Kuttenreich; Dirk Arnold; Jonas Ballmaier; Thomas Lehmann; Winfried Mayr; Orlando Guntinas-Lichius; Gerd Fabian Volk

Mehmet Okur | Working Memory Intervention | Memory Mastery Award

Dr. Mehmet Okur | Working Memory Intervention | Memory Mastery Award

Dr. Mehmet Okur is a researcher and educator specializing in special education, learning disabilities, and cognitive interventions. He holds bachelor’s degrees in Mathematics and Special Education and a Ph.D. in Special Education. As the founder of the Mega-Cognition Center, he develops innovative tools to support cognitive development, attention, and learning difficulties. His research includes early screening tools for learning disabilities, ADHD interventions, and processing speed assessments. Dr. Okur has contributed significantly to special education, collaborating with experts worldwide to advance cognitive and educational research. His work bridges theory and practice, enhancing learning outcomes for individuals with diverse needs.

Profile

Education šŸŽ“

Dr. Mehmet Okur holds dual bachelor’s degrees in Mathematics and Special Education, providing a strong foundation in both analytical and educational sciences. He earned his Ph.D. in Special Education, focusing on cognitive development, learning disabilities, and ADHD. His doctoral research contributed to the development of innovative assessment tools for early detection of learning disabilities. His academic journey includes interdisciplinary studies, integrating cognitive neuroscience with educational psychology. He continuously enhances his expertise through professional training and collaborative research, ensuring his contributions to special education remain cutting-edge and impactful.

Experience šŸ‘Øā€šŸ«

Dr. Mehmet Okur has extensive experience in special education, cognitive research, and intervention program development. As the founder of the Mega-Cognition Center, he designs educational tools for children with learning disabilities and ADHD. His work includes developing the ƖGEBTƖ screening tool, processing speed interventions, and attention assessment tests. He collaborates with institutions and researchers to enhance cognitive and learning strategies. Additionally, he has consulted on educational projects, conducted training workshops, and contributed to national and international research initiatives, making a significant impact on special education and cognitive science.

Research Interests šŸ”¬

Dr. Mehmet Okur’s research revolves around learning disabilities, ADHD, cognitive interventions, and early screening tools. He has developed innovative assessment methods like ƖGEBTƖ for early detection of learning disabilities and interventions to improve processing speed. His work also focuses on executive function training, attention development, and working memory enhancement. He collaborates with cognitive scientists and educators to refine assessment tools and intervention strategies. His research bridges neuroscience and education, aiming to create effective solutions for children with learning challenges, ultimately enhancing their cognitive and academic performance.

Awards & Recognitions šŸ…

Dr. Mehmet Okur has received recognition for his contributions to special education and cognitive research. His development of the ƖGEBTƖ screening tool earned industry and academic acclaim. He has been honored for his work in cognitive interventions, receiving nominations for prestigious awards like the Memory Mastery Award. His contributions to learning disability research, ADHD interventions, and cognitive assessment tools have been acknowledged by professional societies. His dedication to advancing educational methodologies and his commitment to improving cognitive development continue to earn him accolades in the field.

Publications šŸ“š

Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Prof Dr. Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Asst. Prof. Aynur Müdüroğlu Kırmızıbekmez is a neuroscientist at İstanbul Nişantaşı University, specializing in neurodegenerative diseases, neuroprotection, and the gut-brain axis. She completed her Ph.D. in Neuroscience at Istanbul University in 2013 and has been a faculty member since 2014. Her research spans Alzheimer’s, autism, and Parkinson’s disease, focusing on stem cell therapies and functional foods for cognitive enhancement. She has led TÜSEB-approved projects and holds patents on bioactive functional foods. Aynur teaches Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She actively contributes to cutting-edge innovations, particularly in prebiotic-microbiota interactions.

Profile

Education šŸŽ“

Aynur Müdüroğlu Kırmızıbekmez earned her Ph.D. in Neuroscience from Istanbul University in 2013. Her academic journey emphasized neurobiology, neurodegenerative disease mechanisms, and innovative therapeutic strategies. Her doctoral research focused on neuroprotective compounds in Alzheimer’s disease. Before her Ph.D., she pursued studies in molecular biology and biotechnology, refining her expertise in cellular neuroscience. Throughout her education, she collaborated on interdisciplinary projects, integrating neurophysiology with pharmacological advancements. Her postdoctoral research extended into translational neuroscience, bridging laboratory findings with clinical applications. Aynur’s academic foundation laid the groundwork for her extensive research on cognitive function, stem cell therapy, and the gut-brain axis.

Experience šŸ‘Øā€šŸ«

With over a decade of experience, Aynur Müdüroğlu Kırmızıbekmez has been an Assistant Professor at İstanbul Nişantaşı University since 2014. She has led multiple national and international neuroscience projects, including TÜSEB-approved research on Parkinson’s and Alzheimer’s diseases. Aynur has played a pivotal role in developing functional foods aimed at cognitive enhancement and has secured patents for novel bioactive compounds. She actively collaborates with industry and academia, integrating neuroscience with biotechnology. Her teaching portfolio includes Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She has also mentored numerous graduate students in neuropharmacology and neurodegenerative research.

Research Interests šŸ”¬

Aynur Müdüroğlu Kırmızıbekmez’s research focuses on neurodegenerative diseases, neuroprotection, and the gut-brain axis. She explores innovative therapies for Alzheimer’s, Parkinson’s, and autism, with a strong emphasis on stem cell applications. Her work investigates the neuroprotective potential of bioactive compounds and functional foods, aiming to enhance cognitive function. She has pioneered research on the microbiota-brain relationship, particularly the role of prebiotics in neurodegeneration. Aynur’s projects also include SNP-based qPCR diagnostic tools for Alzheimer’s risk assessment. Through interdisciplinary collaborations, she integrates neuroscience with biotechnology, advancing the understanding of cognitive disorders and potential therapeutic interventions.

Awards & Recognitions šŸ…

Aynur Müdüroğlu Kırmızıbekmez has received multiple awards for her contributions to neuroscience, including national research grants and innovation awards for her work on functional foods for neuroprotection. She was honored by TÜSEB for her groundbreaking research in stem cell therapy for Parkinson’s disease. Her patented functional chocolate enriched with bioactive compounds received recognition for its cognitive benefits. Aynur has also been awarded project grants from TÜBİTAK for her research on neurodegeneration. She has been invited as a keynote speaker at international neuroscience conferences and has been recognized for her contributions to cognitive science.

Publications šŸ“š

  • Attila Altunel, Aynur Muduroglu-Kirmizibekmez, Alparslan Onder, Ozlem Altunel, Ali
    Sever, Ihsan Kara, Efficacy of ACTH therapy in children with Landau-Kleffner Syndrome
    and Autism Spectrum Disorder: A retrospective analysis, Epilepsy & Behavior,Vol
    165,2025,110308, https://doi.org/10.1016/j.yebeh.2025.11030
  • Muduroglu-Kirmizibekmez A, Cati C, Onder A, Aydin S, Kara I. Investigation of the acute
    impact of rosemary consumption on brain activity in healthy volunteers. Nutr
    Neurosci. 2024 Jul 6:1-12. doi: 10.1080/1028415X.2024.2370729. Epub ahead of print.
    PMID: 38970803.
  • Biliz Y, Hasdemir B, Başpınar Küçük H, Zaim M, Şentürk AM, Müdüroğlu Kırmızıbekmez
    A, Kara İ. Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents:
    Synthesis and Molecular Docking Studies. ACS Omega. 2023 May 20;8(22):20073-
    20084. doi: 10.1021/acsomega.3c02361. PMID: 37305237; PMCID: PMC10249086.
  • Aydin S, Erƶzden AA, Tavşanlı N, Müdüroğlu A, Ƈalışkan M, Kara İ. Anthocyanin
    Addition to Kefir: Metagenomic Analysis of Microbial Community Structure. Curr
    Microbiol. 2022 Sep 20;79(11):327. doi: 10.1007/s00284-022-03017-x. PMID:
    36125585
  • Altunel Atilla, Müdüroğlu Kirmizibekmez Aynur, Altunel Emine Ɩzlem (2022).
    Hypsarrhythmia Paroxysm Intensities that Initiate and Render Physical & Mental
    Retardation Irreversible in West Syndrome. International Journal of Neuroscience,
    DOI: 10.1080/00207454.2022.2078208 (Publication No: 7685958)

Gerardo Fernandez | Eye tracking | Excellence in Innovation

Dr. Gerardo Fernandez | Eye tracking | Excellence in Innovation

Gerardo Abel FernĆ”ndez šŸ‡¦šŸ‡·, born on October 29, 1976, in BahĆ­a Blanca, Argentina, is a researcher specializing in neuroscience and cognitive science 🧠. He is a professor and adjunct researcher at CONICET, focusing on eye movement-based biomarkers for neurodegenerative diseases šŸ‘€. His work integrates philosophy, cognitive psychology, and technology to advance Alzheimer’s diagnosis šŸ„.

Profile

Education šŸŽ“

šŸŽ“ Gerardo Abel FernĆ”ndez obtained a degree in Philosophy (2003) from Universidad Nacional del Sur (UNS), Argentina, with a specialization in Logic and Epistemology. He later pursued a PhD in Philosophy (2011) at UNS, with his thesis titled “Dynamic word processing during reading: Mental strategies driving visual exploration”, earning a perfect 10/10 with special mention. His academic journey includes postdoctoral research as a fellow at AGENCIA (ANPCYT) and the DAAD Max Planck Institute in Berlin. His educational background bridges philosophy, neuroscience, and cognitive psychology, forming a solid foundation for his pioneering research in eye movement analysis and Alzheimer’s biomarkers. His expertise in cognitive science and technological innovation has led to the development of diagnostic tools for early neurodegenerative disease detection. šŸ“ššŸ”šŸ§ 

Experience šŸ‘Øā€šŸ«

šŸ’¼ Dr. Gerardo Abel FernĆ”ndez has extensive experience in neuroscience research and technological innovation. He served as a Professor of Audiovisual Language at UNS (2011–2013) and is currently an Adjunct Researcher at CONICET, focusing on non-endemic degenerative pathologies. He has worked as a Visiting Scholar at Heriot-Watt University and Strathclyde University (UK), contributing to the development of eye-tracking biomarkers for Alzheimer’s disease. Dr. FernĆ”ndez is also a scientific reviewer for prestigious journals like PlosOne, Journal of Alzheimer’s Disease, and Neuropsychologia. As CTO of Viewmind, he leads biocognitive and functional performance measurement innovations. He has patented cognitive evaluation methods and received grants from institutions like ANPCYT and DAAD. His interdisciplinary expertise spans cognitive neuroscience, machine learning applications in diagnostics, and technological development for neurodegenerative disease assessment. šŸ…šŸ”¬šŸ‘ļø

Research Interests šŸ”¬

šŸ”¬ Dr. Gerardo Abel FernĆ”ndez specializes in cognitive neuroscience, neurodegenerative disease biomarkers, and eye-tracking technology. His research focuses on early Alzheimer’s detection through oculomotor behavior analysis. He has developed innovative methods to study visual exploration, reading difficulties, and memory impairments in neurodegenerative conditions. His work integrates machine learning and artificial intelligence for cognitive assessment tools. As a Visiting Scholar in the UK, he contributed to developing biomarkers for Alzheimer’s disease. His patented eye-tracking system has clinical applications in detecting mild cognitive impairment and Alzheimer’s disease. He has published extensively in peer-reviewed journals, exploring predictive eye movement models and their correlation with cognitive decline. His cutting-edge research bridges philosophy, neuroscience, and technology, offering non-invasive diagnostic solutions for early-stage neurodegeneration. His ultimate goal is to revolutionize cognitive healthcare through technological innovation. šŸ§ šŸ‘ļøšŸ“Š

Awards & Recognitions šŸ…

šŸ† Dr. Gerardo Abel FernĆ”ndez has received numerous awards for his contributions to neuroscience, cognitive evaluation, and Alzheimer’s diagnostics. His eye-tracking research for Alzheimer’s detection earned the Dr. JosĆ© Borda Clinical Psychiatry Prize at the 22nd International Congress of Psychiatry. He won the Novartis Innovation Award for his work on measuring cognitive performance in health and disease. As CTO of Viewmind, his team received international recognition, including the Fit4Start Luxembourg Award for health applications and the Medica Innovation Prize in Düsseldorf. His research and patented cognitive evaluation equipment have been acknowledged by ANMAT (Argentina’s National Administration of Drugs, Foods, and Medical Technology) and INPI (Argentina’s National Patent Office). Dr. FernĆ”ndez’s groundbreaking innovations in neurocognitive assessments have positioned him as a leading figure in technological advancements for early Alzheimer’s detection. šŸ…šŸ§ šŸ”¬

Publications šŸ“š

  • Oculomotor behaviors and integrative memory functions in the alzheimer’s clinical syndrome

    Journal of Alzheimer’s Disease
    2021 |Ā Journal article
  • A non-invasive tool for attention-deficit disorder analysis based on gaze tracks.

    ACM International Conference Proceeding Series
    2019 |Ā Conference paper
  • Microsaccadic behavior when developing a complex dynamical activity

    Journal of Integrative Neuroscience
    2018 |Ā Journal article

    EID:

    2-s2.0-85053731401